Brexit Deal Rejection Sounds Alarm Bells For Pharma Industry
Executive Summary
The UK parliament’s decision to reject the Brexit deal could make the prospect of a no-deal exit more likely, although further votes today and on March 14 could see lawmakers rule out that option – at least for now – and opt instead for an extension of the Article 50 process. Either way, the certainty sought by industry, in particular the life sciences sector, is as far away as ever.